Interim Condensed Statement News Today : Breaking News, Live Updates & Top Stories | Vimarsana

PJSC PhosAgro Consolidated Interim Condensed Financial Statements for the three months ended 31 March 2024 ...

Helix BioPharma Corp. Announces Fiscal Third Quarter 2021 Results OVERVIEW The Company reported a net loss and total comprehensive loss of $2,554,000 and $5,268,000 for the three and nine-month periods ended April 30, 2021. For the three and nine-month periods ended April 30, 2020, net loss and total comprehensive loss totalled $2,489,000 and $6,896,000, respectively. The net loss and total comprehensive loss for the three-month period ending April 30, 2021, includes a net loss of $nil (2020 - $198,000) and for the nine-month period ending April 30, 2021 a gain of $1,536,000 (2020 - loss of $...

Press release content from Accesswire. The AP news staff was not involved in its creation. Helix BioPharma Corp. Announces Fiscal Second Quarter 2021 Results March 16, 2021 GMT RICHMOND HILL, ON / ACCESSWIRE / March 16, 2021 / Helix BioPharma Corp. (TSX:"HBP"), an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the fiscal second ... RICHMOND HILL, ON / ACCESSWIRE / March 16, 2021 / Helix BioPharma Corp. (TSX:"HBP"), an immuno-oncology company developing drug candidates for the prevention and treatment of ...